These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil. Basu C; Ahmed MA; Kartha RV; Brundage RC; Raymond GV; Cloyd JC; Carlin BP J Biopharm Stat; 2016; 26(6):1025-1039. PubMed ID: 27547896 [TBL] [Abstract][Full Text] [Related]
28. Lipoid pneumonia as a complication of Lorenzo's oil therapy in a patient with adrenoleukodystrophy. Majori M; Scarascia A; Anghinolfi M; Pisi R; Gnetti L; Casalini AG J Bronchology Interv Pulmonol; 2014 Jul; 21(3):271-3. PubMed ID: 24992138 [TBL] [Abstract][Full Text] [Related]
33. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease. Hopperton KE; Trépanier MO; James NCE; Chouinard-Watkins R; Bazinet RP Brain Behav Immun; 2018 Mar; 69():74-90. PubMed ID: 29109025 [TBL] [Abstract][Full Text] [Related]
34. Nervonic acid and demyelinating disease. Sargent JR; Coupland K; Wilson R Med Hypotheses; 1994 Apr; 42(4):237-42. PubMed ID: 8072429 [TBL] [Abstract][Full Text] [Related]
35. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy. Zinkham WH; Kickler T; Borel J; Moser HW N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677 [No Abstract] [Full Text] [Related]